MX2023005255A - Composiciones que comprenden metilciclodextrinas para el tratamiento y/o la prevencion de la esteatosis hepatica. - Google Patents

Composiciones que comprenden metilciclodextrinas para el tratamiento y/o la prevencion de la esteatosis hepatica.

Info

Publication number
MX2023005255A
MX2023005255A MX2023005255A MX2023005255A MX2023005255A MX 2023005255 A MX2023005255 A MX 2023005255A MX 2023005255 A MX2023005255 A MX 2023005255A MX 2023005255 A MX2023005255 A MX 2023005255A MX 2023005255 A MX2023005255 A MX 2023005255A
Authority
MX
Mexico
Prior art keywords
prevention
treatment
compositions
hepatic steatosis
methyl cyclodextrins
Prior art date
Application number
MX2023005255A
Other languages
English (en)
Inventor
Daniel Wils
Caroline Perreau
Original Assignee
Roquette Freres
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roquette Freres filed Critical Roquette Freres
Publication of MX2023005255A publication Critical patent/MX2023005255A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

La presente invención se relaciona con un nuevo uso de una composición farmacéutica que comprende al menos una metilciclodextrina en el tratamiento y/o la prevención de la esteatosis hepática y enfermedades relacionadas. La invención también se relaciona con el uso de metilciclodextrina para reducir la acumulación de lípidos en el hígado.
MX2023005255A 2020-11-05 2021-11-04 Composiciones que comprenden metilciclodextrinas para el tratamiento y/o la prevencion de la esteatosis hepatica. MX2023005255A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR2011361A FR3115682B1 (fr) 2020-11-05 2020-11-05 Compositions à base de méthyl-cyclodextrines pour le traitement et/ou la prévention de la stéatose hépatique
PCT/EP2021/025430 WO2022096151A1 (fr) 2020-11-05 2021-11-04 Compositions a base de methyl-cyclodextrines pour le traitement et/ou la prevention de la steatose hepatique

Publications (1)

Publication Number Publication Date
MX2023005255A true MX2023005255A (es) 2023-07-24

Family

ID=75278079

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023005255A MX2023005255A (es) 2020-11-05 2021-11-04 Composiciones que comprenden metilciclodextrinas para el tratamiento y/o la prevencion de la esteatosis hepatica.

Country Status (10)

Country Link
US (1) US20240000827A1 (es)
EP (1) EP4240371A1 (es)
JP (1) JP2023547633A (es)
KR (1) KR20230093516A (es)
CN (1) CN116456991A (es)
AU (1) AU2021374726A1 (es)
CA (1) CA3197127A1 (es)
FR (1) FR3115682B1 (es)
MX (1) MX2023005255A (es)
WO (1) WO2022096151A1 (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001036490A2 (en) 1999-11-12 2001-05-25 Pitha & Pitha Llc Crystalline mixtures of partial methyl ethers of beta-cyclodextrin and related compounds
FR3014694B1 (fr) * 2013-12-13 2016-11-11 Roquette Freres Compositions a base de methyl-cyclodextrines pour le traitement et/ou la prevention de maladies par augmentation du taux de cholesterol-hdl
ES2881228T3 (es) * 2015-02-16 2021-11-29 Univ Queensland Sulfonilureas y compuestos relacionados y uso de los mismos
RO133396A0 (ro) * 2018-12-05 2019-06-28 Universitatea De Vest "Vasile Goldiş" Din Arad Sistem drug delivery crisină - random methyl - beta cyclodextrin () cu potenţial antifibrotic ridicat în prevenţia/regenerarea leziunilor fibrotice hepatice

Also Published As

Publication number Publication date
FR3115682B1 (fr) 2023-02-24
CA3197127A1 (fr) 2022-05-12
EP4240371A1 (fr) 2023-09-13
FR3115682A1 (fr) 2022-05-06
JP2023547633A (ja) 2023-11-13
US20240000827A1 (en) 2024-01-04
WO2022096151A1 (fr) 2022-05-12
AU2021374726A1 (en) 2023-06-08
CN116456991A (zh) 2023-07-18
KR20230093516A (ko) 2023-06-27

Similar Documents

Publication Publication Date Title
ZA202106265B (en) Compositions and methods for inhibiting gene expression of lpa
EP4223316A3 (en) Improved antibody-oligonucleotide conjugate
MA34286B1 (fr) Compositions pharmaceutiques et procédés pour les fabriquer
MX363435B (es) Formulaciones topicas que tienen biodisponibilidad aumentada.
MX2007006171A (es) Composiciones que comprenden ornitina y acetato.
SA519410204B1 (ar) تركيبة تستهدف s1pr4 من أجل الوقاية من التهاب الكبد الدهني غير الكحولي أو علاجه
BR112017016766A2 (pt) composições farmacêuticas para terapia de combinação
EA200870216A1 (ru) Амидо соединения и их применение в качестве лекарственных средств
MX2021010350A (es) Composicion que comprende leuconostoc citreum wikim0104 para prevenir, mejorar o tratar la obesidad o la enfermedad del higado graso.
UA95310C2 (ru) Композиция, содержащая ингибитор chk1 и циклодекстрин, для лечения рака
BR112017016084A2 (pt) composição e método para o tratamento da doença veno-oclusiva hepática
AR078082A1 (es) Composiciones farmaceuticas que comprenden fucanos modificados, metodos y kits relacionados
ATE528990T1 (de) Desinfektions- und entkeimungsmittel
HK1124863A1 (en) Inhibitors of sodium glucose co-transporter 2 and methods of their use
MX2010009270A (es) Compuestos y metodos para la prevencion o tratamiento de reestenosis.
MX2021010349A (es) Composicion para prevenir, mejorar o tratar la obesidad o la enfermedad del higado graso que comprende la weissella hellenica wikim0103.
WO2017163128A3 (en) Use of cyclodextrins to reduce endocytosis in malignant and neurodegenerative disorders
MA32635B1 (fr) Produit medicamenteux et traitement associe
MX2023005255A (es) Composiciones que comprenden metilciclodextrinas para el tratamiento y/o la prevencion de la esteatosis hepatica.
MX2021002902A (es) Composicion farmaceutica para prevenir o tratar la enfermedad del higado graso no alcoholico, que contiene ligando gpr119 como principio activo.
MX2010003914A (es) Nuevas composiciones a base de taxoides.
SG179131A1 (en) Modified erythropoietin to which water-soluble long-chain molecule is added
EP4327807A3 (en) Improved medicinal aerosol formulations
MX2022004203A (es) Profarmacos de inhibidores de mieloperoxidasa.
ZA202002129B (en) Oral bendamustine formulations